Does Humana Cover Wegovy? 2026 Coverage Guide

Does Humana Medicare Advantage Cover Wegovy for Weight Loss?

As of April 2026, a growing number of Humana Medicare Advantage (MA) plans cover FDA-approved weight-management drugs like Wegovy under the Treat and Reduce Obesity Act pathway, which lets MA plans add supplemental obesity-drug coverage that standard Part D cannot offer on its own. Not every Humana MA plan has adopted this yet, and where it has, coverage still requires prior authorization documenting a qualifying BMI (typically 30 or higher, or 27 or higher with a weight-related condition) and often a prior structured weight-management attempt. Check your specific plan's formulary rather than assuming coverage from having Humana Medicare Advantage in general.

Does Humana Cover Wegovy for Cardiovascular Risk Reduction?

This is the pathway the weight-loss-only rule doesn't block. The FDA's 2024 approval covers adults with established cardiovascular disease and either overweight or obesity, based on the SELECT trial, which found a 20% reduction in major adverse cardiovascular events (heart attack, stroke, and cardiovascular death) among more than 17,000 participants without diabetes. Because that indication treats cardiovascular disease rather than weight itself, standard Humana Part D plans can cover Wegovy under this diagnosis even where obesity-only coverage is excluded by statute. Prior authorization documenting the cardiovascular diagnosis, not just a BMI number, is what unlocks this path.

Does Humana Cover Wegovy for MASH (Fatty Liver Disease)?

Wegovy's newest indication, approved August 15, 2025, treats metabolic dysfunction-associated steatohepatitis (MASH) with moderate-to-advanced liver fibrosis, based on the ESSENCE trial showing improvement in liver fibrosis and resolution of steatohepatitis compared with placebo. Like the cardiovascular-risk indication, MASH is a liver-disease diagnosis, not a weight-loss one, so it opens the same kind of standard Part D pathway. A confirmed MASH diagnosis, typically requiring imaging or biopsy evidence of fibrosis, is what a prior authorization request needs to cite for this door. See our Ozempic vs Wegovy comparison for how the two semaglutide brands and their indications differ.

Standard Medicare Part D and the Weight-Loss Statute

Federal law is the reason standard Medicare Part D drug plans, including Humana's, generally cannot cover a GLP-1 medication when the only documented reason is weight loss. The Part D statute specifically excludes "agents when used for anorexia, weight loss, or weight gain" from the covered-drug definition, a rule written long before GLP-1 obesity medications existed. That exclusion is exactly why Wegovy's cardiovascular-risk and MASH indications matter so much for anyone on standard Part D: they're separate, non-weight-loss doors into coverage the statute does not block.

The Medicare GLP-1 Bridge: A Fourth Path, for Weight Loss Specifically

Running from July 1, 2026 through December 31, 2027, the Medicare GLP-1 Bridge is a temporary CMS demonstration that lets eligible Part D beneficiaries access Wegovy, Zepbound (KwikPen only), or Foundayo for weight loss itself at a flat $50 copay per 30-day supply, a copay that does not count toward the plan deductible or the 2026 Part D out-of-pocket cap of $2,100. CMS selected Humana as the nationwide third-party administrator for the entire program, so Humana processes Bridge requests for every participating Part D plan, not only its own members. Reported approval timelines run from about 24 hours to two weeks depending on the submitting carrier.

The Prior Authorization Process, Step by Step

Whichever pathway applies, Humana's prior authorization (PA) process generally follows the same shape:

1. Name the correct indication. Weight management, cardiovascular risk reduction, or MASH each has its own qualifying diagnosis documentation, and naming the wrong one is a common reason a request stalls.
2. Step therapy or prior-attempt evidence (plan-dependent). Some plans require documentation that a structured diet or lifestyle program was tried first.
3. Formulary and tier check. An approved PA can still leave a higher copay if Wegovy sits on a non-preferred formulary tier for a specific plan.
4. Submission and review. Standard reviews commonly take up to two weeks; Bridge program requests route through Humana's central processor regardless of the member's own plan.

An effective appeal after a denial names the specific denial reason and includes a clinical letter addressing it directly, the same appeal discipline described in our broader GLP-1 insurance coverage guide.

Humana Medicaid Plans

Humana also administers Medicaid managed-care plans in several states. Medicaid GLP-1 coverage for weight management specifically is a state-level policy decision, not a Humana-corporate one; roughly 13 states covered a GLP-1 for weight loss under Medicaid as of January 2026, a list that shifts from year to year as states weigh budget pressure against demand. Wegovy's cardiovascular and MASH indications follow a different logic even under Medicaid, since a state's coverage stance on non-weight-loss diagnoses is a separate policy question from its weight-management stance. If you have Humana Medicaid, check your specific state's preferred drug list rather than assuming national policy applies.

If Wegovy Isn't Covered: What It Costs and Where to Save

Wegovy's list price is $1,349 per 28-day supply. Novo Nordisk's own savings programs are the fastest way to lower that cost outside insurance:

• Commercially insured with coverage: the Wegovy Savings Card can bring the cost as low as $25 per fill, subject to a monthly and annual cap.
• Self-pay through NovoCare Pharmacy: a direct-ship cash price around $499 a month, well below list price, with a lower introductory rate on some doses. Confirm the current tiers at novocare.com.
• Medicare Bridge (if eligible): $50 per 30-day supply, as described above.

Government-insurance beneficiaries (Medicare, Medicaid, TRICARE, VA) are typically excluded from manufacturer commercial savings cards by federal law, so the Bridge program and Medicaid's own rules are the relevant paths instead.

What to Look For in a Body-Composition Scale

A bioimpedance scale trends body fat and muscle rather than just weight — useful when the number stalls but your composition is improving. The absolute body-fat % isn't lab-accurate, so use it for TRENDS at a consistent time of day. Choose one that syncs to an app so you can watch the trend line.

GE Smart Scale for Body Weight: 8-Electrode Digital Bathroom Scale for Weight Fat BMI Muscle Mass Full Body Composition Analyzer 50 Measurements Bluetooth Highly Accurate Weighing Machine 400lb Black

GE

View on Amazon →

Etekcity Smart Scale for Body Weight, FSA&HSA Eligible, Bathroom Digital Weighing Scale with BMI, Body Fat, Muscle Mass, Accurate Bluetooth Home User Health Equipment Sync Apps, LED, Tempered glass

Etekcity

View on Amazon →